NEW YORK (Reuters Health) – The outcome of treatment for early prostate cancer depends on the patient’s sexual, bowel and urinary function at baseline. These factors also influence…
NEW YORK (Reuters Health) – For patients with cerebral ischemia, treatment with tissue plasminogen activator (TPA) is known to confer substantial benefit when given within 3 hours of…
NEW YORK (Reuters Health) – Intracoronary nicardipine before elective percutaneous coronary intervention (PCI) does not reduce post-treatment cardiac enzyme leakage in low-risk patients, new research shows. Prior research…
Activity Expiration Please note: This activity has expired. This activity is supported by an educational grant from Eisai, Inc. Release date: July 2009 Expiration date: July 2010 Estimated…
Activity Expiration Please note: This activity has expired. This activity is supported by an educational grant from Eisai, Inc. Release date: July 2009 Expiration date: July 2010 Estimated…
Activity Expiration Please note: This activity has expired. This activity is supported by an educational grant from Eisai, Inc. Release date: July 2009 Expiration date: July 2010 Estimated…
NEW YORK (Reuters Health) – Information from previous colonoscopies may help identify low-risk polypectomy patients who are unlikely to benefit from intense surveillance, a large prospective cohort study…
NEW YORK (Reuters Health) – New research indicates that survival is similar for smokers and non-smokers who undergo liver transplantation. At least one large insurance company is denying…
NEW YORK (Reuters Health) – When patients with acute coronary syndromes receive non-drug-eluting, carbon-coated stents, the rate of binary angiographic restenosis rate at 6 months is low, according…
NEW YORK (Reuters Health) – A phase III clinical trial comparing treatments for relapsed or refractory mantle cell lymphoma indicates that temsirolimus (Wyeth Pharmaceuticals, Philadelphia) significantly improves progression-free…
NEW YORK (Reuters Health) – Findings from the Cardiovascular Health Study-Cognition Substudy suggest that angiotensin-converting enzyme (ACE) inhibitors that cross the blood-brain barrier reduce the risk of incident…
NEW YORK (Reuters Health) – The mortality risk associated with heart failure is increased in indigent patients with comorbid metabolic syndrome, new study findings indicate. “Metabolic syndrome is…
